POTELIGEO – Mogamulizumab uses, dose and side effects
POTELIGEO contains the active substance mogamulizumab, which belongs to a group of medicines called monoclonal antibodies . Mogamulizumab binds to cancer cells which are then destroyed by the immune system (the body’s defenses).
Read More